451. Isorhynchophylline Attenuates MPP + -Induced Apoptosis Through Endoplasmic Reticulum Stress- and Mitochondria-Dependent Pathways in PC12 Cells: Involvement of Antioxidant Activity.
- Author
-
Li XM, Zhang XJ, and Dong MX
- Subjects
- 1-Methyl-4-phenylpyridinium pharmacology, Animals, Dopamine metabolism, Drug Evaluation, Preclinical, Mitochondria metabolism, Neuroprotective Agents pharmacology, Neurotoxins pharmacology, Oxidation-Reduction, Oxidative Stress drug effects, Oxindoles, PC12 Cells, Phosphorylation, Protein Kinases metabolism, Protein Processing, Post-Translational drug effects, Rats, Reactive Oxygen Species metabolism, Signal Transduction drug effects, 1-Methyl-4-phenylpyridinium antagonists & inhibitors, Antioxidants pharmacology, Apoptosis drug effects, Endoplasmic Reticulum Stress drug effects, Indole Alkaloids pharmacology, Mitochondria drug effects, Neurotoxins antagonists & inhibitors
- Abstract
Endoplasmic reticulum stress (ERS) and mitochondrial dysfunctions are thought to be involved in the dopaminergic neuronal death in Parkinson's disease (PD). In this study, we found that isorhynchophylline (IRN) significantly attenuated 1-methyl-4-phenylpyridinium (MPP
+ )-induced apoptotic cell death and oxidative stress in PC12 cells. IRN markedly reduced MPP+ -induced-ERS responses, indicative of inositol-requiring enzyme 1 (IRE1) phosphorylation and caspase-12 activation. Furthermore, IRN inhibits MPP+ -triggered apoptosis signal-regulating kinase 1 (ASK1)/c-Jun N-terminal Kinase (JNK) signaling-mediated mitochondria-dependent apoptosis pathway. IRN-mediated attenuation of endoplasmic reticulum modulator caspase-12 activation was abolished by diphenyleneiodonium (DPI) or IRE-1α shRNA, but not by SP600125 or pifithrin-α in MPP+ -treated PC12 cells. Inhibitions of MPP+ -induced both cytochrome c release and caspase-9 activation by IRN were blocked by pre-treatment with DPI or pifithrin-α, but not by IRE-1α shRNA. IRN blocks the generation of reactive oxygen species upstream of both ASK1/JNK pathway and IRE1/caspase-12 pathway. Altogether, our in vitro findings suggest that IRN possesses potent neuroprotective activity and may be a potential candidate for the treatment of PD.- Published
- 2017
- Full Text
- View/download PDF